The Dow Jones Industrial Average is one of the most prominent and talked about U.S. market indexes. It is a basket of 30 major companies in many different industries, so investing in an exchange-traded fund (ETF) that tracks the index grants investors some level of diversification and could be a great, effortless way to earn solid returns over the long run.

But some individual companies can beat even the mighty Dow Jones, and one of them is biotech giant Eli Lilly (NYSE: LLY). The drugmaker has crushed the Dow over the past decade, and it isn't even close. Here is why Eli Lilly can pull that off again in the next 10 years. 

Continue reading

Source Fool.com